Ecor1 Capital is a private equity firm that specializes in growth equity investments in the technology sector. The firm focuses on partnering with innovative companies that have a positive impact on the environment and society, particularly in the fields of energy, mobility, and sustainability.

Ecor1 Capital

EcoR1 Capital, LLC is a biotech focused investment advisory firm. 

Intellia Therapeutics

Centessa Pharmaceuticals

2seventy bio

Arcus Biosciences

Solid Biosciences

Tango Therapeutics

Cerevel Therapeutics

Nurix Therapeutics

Pardes Biosciences

Ardelyx

Avidity Biosciences

UNITY Biotechnology

Relay Therapeutics

Janux Therapeutics

Kronos Bio

Kymera Therapeutics

Magenta Therapeutics

Neogene Therapeutics

SAGE Therapeutics

Cyclerion Therapeutics

Editas Medicine

Shattuck Labs

Fulcrum Therapeutics

EcoR1 Capital, LLC

Metric
Company Name	Ecor1 Capital
Symbol
MSH ID	COM:ECOR1CAP
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Financial Services
Country
Stage
Employee Count	19
Website	ecor1cap.com
LinkedIn	ecor1-capital-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	3.13K
Web Traffic Growth	-0.30
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ECOR1CAP

Ecor1 Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue